• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    24 Stocks Moving in Tuesday's Pre-Market Session

    6/21/22 6:04:07 AM ET
    $ALV
    $ATHX
    $BHAT
    $CASI
    Auto Parts:O.E.M.
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ALV alert in real time by email

    Gainers

    • Valneva SE (NASDAQ:VALN) shares rose 83.6% to $25.18  in pre-market trading following Pfizer agreement to acquire an 8.1% stake.
    • Grove Collaborative Holdings, Inc. (NASDAQ:GROV) rose 44.8% to $14.48 in pre-market trading after jumping 68% on Friday.
    • Minerva Neurosciences, Inc. (NASDAQ:NERV) rose 36.7% to $0.54 in pre-market trading.
    • Endo International plc (NASDAQ:ENDP) shares rose 23.1% to $0.4315 in pre-market trading. TLC BioSciences recently entered a commercialization agreement with Endo International for the U.S. rights of TLC599, a proprietary BioSeizer sustained-release injectable in Phase 3 development for osteoarthritis pain.
    • RedHill Biopharma Ltd. (NASDAQ:RDHL) rose 19.4% to $0.76 in pre-market trading. RedHill Biopharma is expected to report its first quarter 2022 financial results and operational highlights on Thursday, June 23, 2022.
    • Mereo BioPharma Group plc (NASDAQ:MREO) rose 16.9% to $1.52 in pre-market trading. Mereo BioPharma shares jumped over 62% on Friday following reports suggesting AstraZeneca is weighing a bid for Mereo BioPharma.
    • Revlon, Inc. (NYSE:REV) rose 13.4% to $4.23 in pre-market trading. Revlon shares jumped 91% on Friday following a report suggesting Reliance Industries is considering buying out the company, which recently filed for bankruptcy.
    • Spirit Airlines, Inc. (NYSE:SAVE) rose 12.7% to $24.00 in pre-market trading. Spirit Airlines’ board announced they will review revised proposal from JetBlue Airways Corporation.
    • Resolute Forest Products Inc. (NYSE:RFP) shares rose 12.4% to $15.50 in pre-market trading. The company, last month, posted downbeat quarterly earnings.
    • Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) rose 10.7% to $0.7749 in pre-market trading. Hepion Pharmaceuticals received FDA orphan drug status designation for rencofilstat for the treatment of hepatocellular carcinoma.
    • Jaguar Health, Inc. (NASDAQ:JAGX) shares rose 10.7% to $0.2995 in pre-market trading after declining 7% on Friday.
    • Autoliv, Inc. (NYSE:ALV) rose 8.8% to $75.12 in pre-market trading. Autoliv reiterated its full-year 2022 indications.
    • CASI Pharmaceuticals, Inc. (NASDAQ:CASI) rose 8.7% to $3.24 in pre-market trading.
    • Murphy Oil Corporation (NYSE:MUR) rose 8.5% to $36.50 in pre-market trading after declining 7% on Friday.
    • Athersys, Inc. (NASDAQ:ATHX) rose 7.6% to $0.3002 in pre-market trading after declining 13% on Friday.


    Don’t forget to check out our premarket coverage here .

    Losers

    • Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ:BHAT) shares fell 48.2% to $0.60 in pre-market trading. Blue Hat Interactive Entertainment Technology reported a proposed underwritten public offering of ordinary shares and pre-funded warrants to purchase ordinary shares.
    • UTStarcom Holdings Corp. (NASDAQ:UTSI) fell 12.5% to $0.70 in pre-market trading.
    • Electric Last Mile Solutions, Inc. (NASDAQ:ELMS) fell 11.9% to $0.3216 in pre-market trading after surging 29% on Friday. Electric Last Mile recently anounced plans to filed for Chapter 7 bankruptcy.
    • NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) fell 10.1% to $0.38 in pre-market trading.
    • SoundHound AI, Inc. (NASDAQ:SOUN) fell 9.8% to $3.61 in pre-market trading after jumping around 50% on Friday.
    • Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) shares fell 9.2% to $4.03 in pre-market trading. Comera Life Sciences shares jumped around 27% on Friday after the company was granted a US patent titled 'Excipient compounds for protein processing.'
    • COMSovereign Holding Corp. (NASDAQ:COMS) shares fell 9.1% to $0.1585 in pre-market trading.
    • Wah Fu Education Group Limited (NASDAQ:WAFU) shares fell 8.8% to $2.06 in pre-market trading.
    • Motorsport Games Inc. (NASDAQ:MSGM) fell 8.4% to $0.4156 in pre-market trading after declining around 27% on Friday.
    Get the next $ALV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALV
    $ATHX
    $BHAT
    $CASI

    CompanyDatePrice TargetRatingAnalyst
    Mereo BioPharma Group plc
    $MREO
    12/30/2025$0.50Buy → Hold
    Jefferies
    Autoliv Inc.
    $ALV
    11/26/2025$140.00Neutral → Overweight
    Analyst
    Murphy Oil Corporation
    $MUR
    11/18/2025$34.00Overweight → Neutral
    Piper Sandler
    Autoliv Inc.
    $ALV
    10/10/2025Buy → Hold
    Deutsche Bank
    Autoliv Inc.
    $ALV
    10/7/2025$124.00Buy → Neutral
    UBS
    Valneva SE
    $VALN
    8/19/2025$18.00Buy
    H.C. Wainwright
    Autoliv Inc.
    $ALV
    7/2/2025$140.00Buy
    Jefferies
    Autoliv Inc.
    $ALV
    6/25/2025$133.00Outperform
    RBC Capital Mkts
    More analyst ratings

    $ALV
    $ATHX
    $BHAT
    $CASI
    SEC Filings

    View All

    SEC Form 6-K filed by CASI Pharmaceuticals Inc.

    6-K - CASI Pharmaceuticals, Inc. (0001962738) (Filer)

    2/10/26 9:00:14 AM ET
    $CASI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13D/A filed by CASI Pharmaceuticals Inc.

    SCHEDULE 13D/A - CASI Pharmaceuticals, Inc. (0001962738) (Subject)

    2/10/26 6:01:54 AM ET
    $CASI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form F-1 filed by Blue Hat Interactive Entertainment Technology

    F-1 - Blue Hat Interactive Entertainment Technology (0001759136) (Filer)

    2/9/26 5:02:30 PM ET
    $BHAT
    Recreational Games/Products/Toys
    Consumer Discretionary

    $ALV
    $ATHX
    $BHAT
    $CASI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Mereo BioPharma downgraded by Jefferies with a new price target

    Jefferies downgraded Mereo BioPharma from Buy to Hold and set a new price target of $0.50

    12/30/25 7:20:11 AM ET
    $MREO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Autoliv upgraded by Analyst with a new price target

    Analyst upgraded Autoliv from Neutral to Overweight and set a new price target of $140.00

    11/26/25 8:30:09 AM ET
    $ALV
    Auto Parts:O.E.M.
    Consumer Discretionary

    Murphy Oil downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Murphy Oil from Overweight to Neutral and set a new price target of $34.00

    11/18/25 8:19:40 AM ET
    $MUR
    Oil & Gas Production
    Energy

    $ALV
    $ATHX
    $BHAT
    $CASI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Users Validate Leostream Platform in HPC Environments

    Remote workspace leader valued for improved GPU orchestration, faster session performance for visualization and simulation, stronger cloud/hybrid cloud support Leostream Corporation, creator of the world-leading Leostream® Remote Desktop Access Platform, has gained traction with customers using the platform in high-performance computing environments such as engineering, subsurface exploration, and other graphics- and data-intensive workloads. Customers report improved GPU orchestration, faster session performance for visualization and simulation, and stronger cloud/hybrid cloud support. Customers praised the platform for simplifying secure access to HPC environments by managing connecti

    2/10/26 8:58:00 AM ET
    $MUR
    Oil & Gas Production
    Energy

    Valneva and Instituto Butantan Announce Initiation of a Pilot Vaccination Campaign in Brazil with Single-Shot Chikungunya Vaccine IXCHIQ®

    Lyon (France), Sao Paulo, (Brazil), February 3, 2026 –Valneva SE  (NASDAQ:VALN, PARIS:VLA), a specialty vaccine company and Instituto Butantan, one of the world's largest biomedical research centers, today announced the initiation of a Pilot Vaccination Strategy (PVS) in Brazil using Valneva's single-shot chikungunya vaccine, IXCHIQ®. The pilot vaccination program will serve as the basis for post-marketing commitment studies evaluating the effectiveness and safety of IXCHIQ® in a real-world setting and generating real-world evidence in a large population. The PVS, agreed between the Brazilian Ministry of Health (MoH) and Instituto Butantan, will be implemented in ten Brazilian municipaliti

    2/3/26 1:00:00 AM ET
    $VALN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Autoliv: Financial Report October - December 2025

    STOCKHOLM, Jan. 30, 2026 /PRNewswire/ -- (NYSE:ALV) and (SSE: ALIV.sdb) Q4 2025: Our best quarter yet Financial highlights Q4 2025 $2,817 million net sales 7.7% net sales increase4.2% organic sales growth*11.3% operating margin12.0% adjusted operating margin*$2.98 diluted EPS, 4% decrease$3.19 adjusted diluted EPS*, 5% increase Full year 2026 guidance Around 0% organic sales growthAround 1% positive FX effect on net salesAround 10.5-11.0% adjusted operating marginAround $1.2 billion operating cash flow All change figures in this release compare to the same period of the previous year except when stated otherwise. Key business developments in the fourth quarter of 2025 Net sales increased or

    1/30/26 6:47:00 AM ET
    $ALV
    Auto Parts:O.E.M.
    Consumer Discretionary

    $ALV
    $ATHX
    $BHAT
    $CASI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Murphy Robert Madison gifted 4,345 shares and received a gift of 2,896 shares (SEC Form 4)

    4 - MURPHY OIL CORP (0000717423) (Issuer)

    2/10/26 12:03:55 PM ET
    $MUR
    Oil & Gas Production
    Energy

    Director Tudor Robert B Iii converted options into 7,886 shares, increasing direct ownership by 541% to 9,345 units (SEC Form 4)

    4 - MURPHY OIL CORP (0000717423) (Issuer)

    2/6/26 12:24:54 PM ET
    $MUR
    Oil & Gas Production
    Energy

    SEC Form 4 filed by Director Sugg Laura A

    4 - MURPHY OIL CORP (0000717423) (Issuer)

    2/6/26 12:23:52 PM ET
    $MUR
    Oil & Gas Production
    Energy

    $ALV
    $ATHX
    $BHAT
    $CASI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Delta John bought $13,020 worth of shares (5,000 units at $2.60), increasing direct ownership by 71% to 12,000 units (SEC Form 4)

    4 - Motorsport Games Inc. (0001821175) (Issuer)

    12/12/25 5:31:22 PM ET
    $MSGM
    Computer Software: Prepackaged Software
    Technology

    Director Delta John bought $20,426 worth of shares (7,000 units at $2.92) (SEC Form 4)

    4 - Motorsport Games Inc. (0001821175) (Issuer)

    8/21/25 4:05:22 PM ET
    $MSGM
    Computer Software: Prepackaged Software
    Technology

    Director Nolan Jeffrey W bought $233,947 worth of shares (10,000 units at $23.39) (SEC Form 4)

    4 - MURPHY OIL CORP (0000717423) (Issuer)

    3/5/25 4:39:33 PM ET
    $MUR
    Oil & Gas Production
    Energy

    $ALV
    $ATHX
    $BHAT
    $CASI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Spirit Airlines Inc.

    SC 13G - Spirit Airlines, Inc. (0001498710) (Subject)

    12/6/24 9:37:58 AM ET
    $SAVE
    Air Freight/Delivery Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Mereo BioPharma Group plc

    SC 13G/A - Mereo BioPharma Group plc (0001719714) (Subject)

    11/14/24 4:18:45 PM ET
    $MREO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Hepion Pharmaceuticals Inc.

    SC 13G/A - Hepion Pharmaceuticals, Inc. (0001583771) (Subject)

    11/14/24 4:07:59 PM ET
    $HEPA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALV
    $ATHX
    $BHAT
    $CASI
    Leadership Updates

    Live Leadership Updates

    View All

    Minerva Neurosciences Appoints Dr. Inderjit Kaul to the Company's Board of Directors

    BURLINGTON, Mass., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced the appointment of Dr. Inderjit Kaul, Chief Medical Officer of Draig Therapeutics, to the board of directors. Dr. Kaul will also serve as a consultant to the Company for the future clinical development of roluperidone. Last month, the Company announced successfully raising up to $200 million in a private placement to fund a confirmatory Phase 3 trial for roluperidone for the treatment of negative symptoms in patients with schizophrenia, resubmission of it

    11/19/25 8:30:00 AM ET
    $NERV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Valneva Announces Exclusive Vaccine Marketing and Distribution Agreement for Germany with CSL Seqirus

    Saint-Herblain, France, June 26, 2025 – Valneva SE, (NASDAQ:VALN, PARIS:VLA), a specialty vaccine company, today announced an exclusive agreement with CSL Seqirus, one of the world's largest influenza vaccine companies, for the marketing and distribution of Valneva's three proprietary vaccines in Germany. Under the agreed terms, CSL Seqirus will start commercializing Valneva's single-dose chikungunya vaccine IXCHIQ® from July 2025, and Valneva's Japanese Encephalitis vaccine IXIARO® and cholera/ETEC1 vaccine DUKORAL® from January 2026. This new agreement with CSL Seqirus replaces the marketing and distribution agreement Valneva signed with Bavarian Nordic in 20212, which is due to conclude

    6/26/25 1:00:00 AM ET
    $VALN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Valneva Announces Successful Outcome of its Annual General Meeting, Confirms FY 2025 guidance

    Saint-Herblain (France), June 25, 2025 – Valneva SE (NASDAQ:VALN, PARIS:VLA), a specialty vaccine company, today announced that all the resolutions recommended by the Board of Directors were approved by the shareholders at its Annual General Meeting held today in Lyon, France. Among the adopted resolutions were the approval of the 2024 financial statements, delegations for the Board of Directors to increase Valneva's share capital and/or issue financial instruments, the appointment of Dr. Gerd Zettlmeissl to the Board for a three-year term and the reappointment of Mr. James Sulat for a one-year term. Dr. Gerd Zettlmeissl is a vaccine expert and Biotech Entrepreneur with more than 30 years

    6/25/25 11:45:00 AM ET
    $VALN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ALV
    $ATHX
    $BHAT
    $CASI
    Financials

    Live finance-specific insights

    View All

    Autoliv: Financial Report October - December 2025

    STOCKHOLM, Jan. 30, 2026 /PRNewswire/ -- (NYSE:ALV) and (SSE: ALIV.sdb) Q4 2025: Our best quarter yet Financial highlights Q4 2025 $2,817 million net sales 7.7% net sales increase4.2% organic sales growth*11.3% operating margin12.0% adjusted operating margin*$2.98 diluted EPS, 4% decrease$3.19 adjusted diluted EPS*, 5% increase Full year 2026 guidance Around 0% organic sales growthAround 1% positive FX effect on net salesAround 10.5-11.0% adjusted operating marginAround $1.2 billion operating cash flow All change figures in this release compare to the same period of the previous year except when stated otherwise. Key business developments in the fourth quarter of 2025 Net sales increased or

    1/30/26 6:47:00 AM ET
    $ALV
    Auto Parts:O.E.M.
    Consumer Discretionary

    Quarterly Stockholder Update by Murphy Oil Corporation

    Murphy Oil Corporation (NYSE:MUR): Murphy Oil Corporation Stockholders, This letter serves as a supplement to our earnings release for the fourth quarter of 2025. Please see the information regarding forward-looking statements and non-GAAP financial information1 included at the end of this letter. Unless otherwise noted, the financial and operating highlights and metrics discussed in this letter exclude noncontrolling interest (NCI).2 2025 IN REVIEW 2025 was a pivotal year for Murphy, marked by momentum in our exploration program and strong execution in our core business. We delivered some of the best wells in Company history in onshore US and Canada, accompanied by robust execution

    1/28/26 4:42:00 PM ET
    $MUR
    Oil & Gas Production
    Energy

    Murphy Oil Corporation Announces Fourth Quarter and Full Year 2025 Results, Preliminary Year-End 2025 Reserves, 2026 Capital Expenditure and Production Guidance

    Announced Successful Appraisal Well at Hai Su Vang-2X in Offshore Vietnam, Maintained 11 Year Reserve Life with Preliminary Proved Reserves of 715 MMBOE, Signed Petroleum Agreement for Morocco New Country Entry, Increased Dividend by 8 Percent in 2026 Murphy Oil Corporation (NYSE:MUR) today announced its financial and operating results for the fourth quarter ended December 31, 2025. As a supplement to this release, Murphy has also furnished a Quarterly Stockholder Update. Unless otherwise noted, the financial and operating highlights and metrics discussed in this commentary exclude noncontrolling interest (NCI).† (Millions of dollars, except volumes and per share amounts) Thre

    1/28/26 4:41:00 PM ET
    $MUR
    Oil & Gas Production
    Energy